Agreement between self-report and urine drug test results in a sample patients treated with buprenorphine for opioid use disorder
BACKGROUND: Urine drug testing (UDT) is recommended to monitor primary care patients treated for opioid use disorder with buprenorphine. Whether UDT data contributes clinically useful information beyond patient self-report of drug use has received minimal attention. It is unclear whether differences...
Main Author: | |
---|---|
Language: | en_US |
Published: |
2018
|
Subjects: | |
Online Access: | https://hdl.handle.net/2144/27116 |